Long-Term Diabetic Microenvironment Augments the Decay Rate of Capsaicin-Induced Currents in Mouse Dorsal Root Ganglion Neurons

Abstract

Introduction Individuals diagnosed with diabetes mellitus are at increased risk of developing microcomplications of the disease, including diabetic retinopathy, renal failure, and peripheral neuropathy. Changes in Blood Glucose Level, Body Weight Ins2+/Akita mouse is a hereditary model of diabetes [18,19,20]. High Glucose Decreased the Capsaicin-Evoked [Ca2+]i-Responses and Increased Intracellular ROS Accumulation We next investigated the effect of treatment with 25 mM glucose on capsaicin-induced [Ca2+]i increases and ROS production in wild-type DRG neurons to ascertain whether there is a correlation between the elevated glucose, ROS, and TRPV1 function. [...]we demonstrate that the percentage of capsaicin-sensitive neurons is higher in the primary cultures

1. Introduction

Individuals diagnosed with diabetes mellitus are at increased risk of developing microcomplications of the disease, including diabetic retinopathy, renal failure, and peripheral neuropathy. Peripheral neuropathy is one of the most common complications of end-stage diabetes, which manifests as symmetrically decreased pain sensation in the lower extremities and is associated with a high incidence of foot ulceration. A retrospective study in 2015 estimated the prevalence of peripheral neuropathy to be about 30% in diabetic patients [1], while other studies have reported up to 80% [2,3].

Despite the high prevalence of this condition, the mechanisms underlying this dysfunction are poorly understood, limiting the development of new therapeutic strategies. The peripheral processes of dorsal root ganglion (DRG) neurons innervate the cutaneous surface of the foot. The transient receptor potential vanilloid type 1 (TRPV1) channel is a Ca²⁺ permeable plasma membrane cation channel that can be activated by heat, acid, and capsaicin [4,5,6] and is expressed robustly in the nociceptive sensory neurons of DRG [7,8]. TRPV1 is known to be upregulated in a number of clinical disease-associated pain conditions [9,10,11,12]. Animal models of induced diabetes have demonstrated increased TRPV1 expression that correlates to hyperalgesia and decreased TRPV1 expression in hypoalgesia [13], reflecting earlier and later manifestations of diabetic neuropathy, respectively.

Elevated Reactive Oxygen Species (ROS) are associated with the pathogenesis of diabetes and diabetic complications [14]. Hyperglycemia is the major trigger of ROS accumulation in diabetes. Notably, TRPV1 channels are sensitive to ROS. It has been demonstrated that H₂O₂ activates TRPV1 and potentiates the capsaicin-induced TRPV1 currents after short-term treatment and that the prolonged treatment with H₂O₂ reduced the capsaicin-induced TRPV1 current amplitude in human embryonic kidney (HEK) cells [15,16]. ROS are known to be elevated in hereditary model of diabetes, such as Ins2^+/Akita mice, exhibiting hyperglycemia and hypoinsulinemia, but no obesity [17].

In this study, we investigated the function activity of TRPV1 in DRG neurons from long-term diabetic Ins2^+/Akita mice to determine whether TRPV1 activity is modulated under a diabetic environment. We also assessed short-term changes in high glucose-induced ROS accumulation in DRG neurons.

2. Results 2.1. Changes in Blood Glucose Level, Body Weight

Ins2^+/Akita mouse is a hereditary model of diabetes [18,19,20]. In this study, only male wild-type and Ins2^+/Akita mice were used as the male Ins2^+/Akita mice show more profound diabetic phenotype than the female mice [19,20]. Mice were observed for a period of 36 weeks after the onset of diabetes. Blood glucose levels were significantly elevated within 6 weeks and remained elevated (520 ± 21.4 mg/dL, n = 4) as compared to control non-diabetic mice (216 ± 27.2 mg/dL, n = 4). As the disease progressed (9 months after the onset of diabetes), the overall body weight of the Ins2^+/Akita mice (23.1 ± 1.8 g, n = 6) was much lower when compared to their wild-type littermates (40.7 ± 1.7 g, n = 6).

2.2. Increased Positive TRPV1 Staining DRGs Neurons in Ins2^+/Akita Mice

Studies using Ins2^+/Akita mice reportedly exhibit impaired thermal nociception at an age of 12 weeks [21]. Channels thought to contribute to these changes include TRPV1, which is known to be upregulated in several clinical disease-associated pain conditions [9,10,11,12]. Consistently, Figure 1A,B shows that a greater number of neurons are TRPV1 positive in Ins2^+/Akita DRGs (27.3 ± 1.83%, n = 7, 42 section slices from seven Ins2^+/Akita mice) when compared with wild-type DRGs (18.0 ± 1.56%, n = 7, 42 section slices from seven wild-type mice).

2.3. Capsaicin-Evoked [Ca²⁺]_i Responses in Wild-Type and Ins2^+/Akita DRGs

Capsaicin, a member of the vanilloid family, binds to TRPV1 and depolarizes isolated sensory neurons. In Figure 1C,D, we can see that the percentage of isolated DRG neurons (cultured overnight after isolation) sensitive to capsaicin (100 nM) in the Ins2^+/Akita group (42.7 ± 6.5%, 321 cells from six mice) was not different from the wild-type group (49.8 ± 7.2%, 337 cells from five mice). However, the capsaicin-induced intracellular calcium increases in Ins2^+/Akita neurons (ΔF340/F380*s = 0.26 ± 0.04, n = 6, 321 cells from six mice) were significantly smaller than those in wild-type neurons (ΔF340/F380*s = 0.43 ± 0.05, n = 5, 337 cells from five mice). The intracellular calcium increases induced by 70 KCl was not different between the Ins2^+/Akita and wild-type (right inset in Figure 1C). These data suggest that TRPV1 function may be impaired in diabetic Ins2^+/Akita DRG neurons.

2.4. Voltage-Gated Calcium and TRPV1 Currents in Wild-Type and Ins2^+/Akita DRG Neurons

Ion channels, such as voltage-gated potassium channels, are known to be altered in neurons derived from diabetic rodents [22]. To determine the degree to which voltage-gated Ca²⁺ channels were affected by a diabetic environment, we measured voltage-gated Ca²⁺ currents in small-and mid-sized Ins2^+/Akita and wild-type DRG neurons. The cells were cultured overnight before the whole cell patch-clamp experiments. We found that the voltage-gated Ca²⁺ current amplitudes were not different in Ins2^+/Akita (−157.9 ± 23.4 pA/pF, n = 15) and wild-type (−147.7 ± 21.1 pA/pF, n = 15, Figure 2A,B) groups. This was in accordance with our Ca²⁺-imaging experiments where 70 KCl induced similar calcium changes in Ins2^+/Akita and wild-type neurons (Figure 1C, inset). We next assessed the function of TRPV1 using capsaicin (2 μM) applications. Figure 2C,D illustrate that the average peak TRPV1 current amplitudes were not significantly different in Ins2^+/Akita neurons (−103.0 ± 24.8 pA/pF, n = 7) and wild-type neurons (−67.8 ± 17.5 pA/pF, n = 7). However, the TRPV1 currents decayed faster after reaching the peak value in Ins2^+/Akita neurons than wild-type (Figure 2C insets). To evaluate the current decay, the areas under the curve of capsaicin-induced currents were calculated. Figure 2E shows that the Ins2^+/Akita neurons had significantly smaller areas under the curve during capsaicin application (63.0 ± 15.5, n = 7) than wild-type neurons (126.1 ± 22.3, n = 7). Although Ins2^+/Akita and wild-type neurons had similar capsaicin-induced peak currents, the currents decayed much faster (Figure 2F, time constant: 91.5 ± 10.3 s vs 32.9 ± 8.1 s, respectively).

2.5. High Glucose Decreased the Capsaicin-Evoked [Ca²⁺]_i-Responses and Increased Intracellular ROS Accumulation

We next investigated the effect of treatment with 25 mM glucose on capsaicin-induced [Ca²⁺]_i increases and ROS production in wild-type DRG neurons to ascertain whether there is a correlation between the elevated glucose, ROS, and TRPV1 function. Isolated DRG neurons from wild-type C57BL/6J mice were treated with 25 mM glucose (25HG) for 7 days to mimic the diabetic environment. The percentage of cultured DRG neurons sensitive to capsaicin (100 nM) in the 25HG treated group was not different from that observed in the control group. The DRG neurons treated with 25HG had significantly smaller intracellular calcium increases evoked by 100 nM capsaicin than control neurons treated with only 5.5 mM glucose (Figure 3A,B, ΔF340/F380*s = 0.36 ± 0.19 vs ΔF340/F380*s = 1.27 ± 0.26, respectively). Notably, the 15 mM KCl-induced [Ca²⁺]_i responses were smaller in DRG neurons treated with 25 mM glucose compared to control DRG neurons (Figure 3A, inset). The cytoplasmic redox state was monitored using a ROS sensitive dye, 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) [23,24], in cultured neurons under control and 25HG conditions. The DCFH-DA fluorescence intensity in DRG neurons from 25HG-treated group was significantly increased as compared to that in the control group (Figure 3C,D, 25HG: 0.83 ± 0.01, n = 585; control: 0.66 ± 0.01, n = 765). These data suggest that the functional change of TRPV1 in short-term diabetic conditions correlates with the increased levels of cytoplasmic ROS.

3. Discussion

The major novel finding in this study is the fact that capsaicin-induced currents exhibit a markedly accelerated rate of decay in Ins2^+/Akita DRG neurons at 9 months of diabetes compared to DRG neurons isolated from control DRGs. In addition, our data show that the TRPV1 expression is increased in end-stage diabetes. However, the capsaicin-induced calcium responses are decreased, suggesting the impaired TRPV1 function in diabetic DRG neurons. Consistent with previous reports [25,26], we observed an increased production of ROS in DRG neurons cultured in the presence of 25 mM of glucose, simulating a hyperglycemic state. The electrophysiological recordings do not show impairment in the function of voltage-gated Ca²⁺ channels in Ins2^+/Akita DRG neurons compared to control DRG neurons.

Several studies, using streptozotocin (STZ)-treated mice, a model of type 1 diabetes, reported that in DRG neurons, elevated TRPV1 expression is associated with hyperalgesia and decreased TRPV1 expression is linked to loss of pain sensation (hypoalgesia) [13,27]. There are several mechanisms underlying the hyperalgesic phenotype in short-term diabetes, involving long non-coding RNA BC168687 [28] and protein kinase C (PKC) activation [29]. However, it remains unclear how TRPV1 function and expression are modulated in hypoalgesia associated with end-stage diabetes.

Our data suggest that the percentage of TRPV1-positive neurons is increased in intact DRGs from 9-month diabetic Ins2^+/Akita mice as determined by immunohistochemistry, whereas in cultured DRG neurons, isolated from the same animals, the percentage of capsaicin-sensitive neurons is not different between the diabetic and control groups as ascertained using the calcium imaging assay (Figure 1). Moreover, we demonstrate that the percentage of capsaicin-sensitive neurons is higher in the primary cultures than expected from the immunohistochemistry data. This apparent discrepancy may result from several factors. Firstly, survival of certain populations of neurons may be variably affected during the DRG dissociation procedure and short-term culture. Secondly, the TRPV1 protein is known to be expressed on both the plasma membrane and the endoplasmic reticulum in sensory neurons [30], whereas the calcium imaging assay evaluates TRPV1 function only in the plasma membrane at nanomolar concentrations of capsaicin. The degree to which the observed protein changes affect mechanical and thermal nociception is unknown. However, it was reported that 5-month diabetic Ins2^+/Akita mice already presented with impaired mechanical and thermal nociception [21]. This is consistent with our calcium imaging and electrophysiology data revealing that TRPV1 activity decays much faster in Ins2^+/Akita DRG neurons at 9 months of diabetes.

A recent study reported a RAGE (receptor for Advanced Glycation End-products)-dependent potentiation of TRPV1 currents in sensory neurons exposed to high glucose, implicating RAGE in modulating TRPV1 [25], with high glucose treated DRG neurons showing potentiated capsaicin-evoked TRPV1 currents and elevated intracellular ROS accumulation [25]. In our study, high glucose treatment of DRG neurons also resulted in an increase in ROS production (Figure 3C). However, we observed reduced capsaicin-stimulated responses in high glucose treated DRG neurons. We also did not observe the potentiated peak amplitudes of capsaicin-induced currents in Ins2^+/Akita DRG neurons at 9 months of diabetes compared to control DRG neurons (Figure 2C–E), and we found that the currents exhibited much faster decays (Figure 2F). Consistently, smaller capsaicin-induced intracellular calcium changes were observed in Ins2^+/Akita DRG neurons compared to wild-type neurons (Figure 1C,E). In the previously cited study, data was obtained from neonatal or 2 to 3-month-old mice, while we used >9 month-old mice. Therefore, we cannot exclude that our differing observations may be due to animal age. Moreover, ligands that can accompany diabetic conditions and activate RAGE, such as the inflammatory cytokine high-mobility group box-protein 1 (HMGB1, also known as amphoterin) and methylglyoxal, may contribute to pain behavior in diabetic neuropathy via TRPV1 or transient receptor potential ankyrin 1 (TRPA1)-dependent mechanisms [31,32].

The observed facilitated decay of TRPV1 activity reported in this study may be due to accelerated desensitization of the channel. The mechanisms of the TRPV1 desensitization are diverse and may involve multiple intracellular signaling pathways, and the process is often Ca²⁺-dependent [33]. Notably, long capsaicin exposure induced TRPV1 endocytosis and degradation and decrease in TRPV1 activity [34]. It is well known that phosphorylation of TRPV1 sensitizes the channel [35]. Consistently, dephosphorylation of p-TRPV1 by the phosphatase calcineurin was shown to lead to TRPV1 desensitization [36]. Several other mechanisms of TRPV1 desensitization were also proposed such as binding of calmodulin [37] and the depletion of phosphatidylinositol 4,5-diphosphate from the plasma membrane [38]. Future experiments will be needed to establish whether these processes modulate TRPV1 activity in the setting of end-stage diabetes.

Chuang and Lin reported that H₂O₂ activates TRPV1 and potentiates the capsaicin-induced TRPV1 currents [15], whereas DelloStritto et al. (2016, [16]) demonstrated that the prolonged treatment with H₂O₂ reduced the capsaicin-induced TRPV1 current amplitude in HEK cells. Thus, ROS might modulate TRPV1 activity. The mechanism for H₂O₂-dependent modulation of TRPV1 function remains to be determined. Ca²⁺ influx through TRPV1 may facilitate Ca²⁺-dependent desensitization of the channel [39], signifying that H₂O₂ may be a possible factor in the inhibitory effect of diabetic environment on TRPV1 through a Ca²⁺ dependent mechanism. Alternatively, Chuang and Lin (2009) reported [15] that marked H₂O₂-dependent sensitization of TRPV1 might be due to the formation of disulfide bonds, likely between the N-terminal C158 and the C-terminal C783. Further experiments will be needed to determine whether Ca²⁺ influx or H₂O₂–dependent specific cysteine residue oxidation and reversible disulfide bond formation [40] underlies the accelerated TRPV1 current decay observed in Akita DRG neurons at 9 months of diabetes. Long-term in vivo treatment with antioxidants in diabetic Akita mice will be needed to provide evidence whether an association exists between long-term ROS accumulation and the accelerated kinetics of TRPV1 current decay observed in end-stage diabetes.

A subset of TRPV1-positive DRG neurons co-expresses the TRPA1 channel. It has been reported that TRPA1 and TRPV1 channels can interact physically and functionally [41,42,43]. Notably, heterologous desensitization between these two channels may occur in DRG neurons [41]. Since H₂O₂ also activates TRPA1 [44], it is possible that ROS-dependent activation of TRPA1 channels followed by heterologous TRPV1 desensitization may lead to accelerating the TRPV1 current decay rate. On the other hand, a recent study [43] provided evidence that in TRPA1-positive DRG neurons, the decay rate of capsaicin-induced currents was apparently slower due to cross-activation of TRPA1 by capsaicin-induced calcium influx, suggesting that TRPA1 protein depletion may result in accelerating the decay rate of capsaicin-induced currents. Thus, it remains to be determined whether cross-desensitization or cross-activation between TRPA1 and TRPV1 would prevail in regulating TRPV1 current kinetics in diabetes.

In addition to being activated by low pH and capsaicin, TRPV1 is also activated by heat. A recent study [21] found reduced behavioral sensitivity to noxious heat associated with a reduced temperature-activated [Ca²⁺]_i-response amplitude in DRG neurons from Ins2^+/Akita mice at 20 weeks of diabetes. However, the authors reported that no difference was observed in capsaicin-evoked [Ca²⁺]_i responses in wild-type and Ins2^+/Akita DRG neurons. We found decreased overall capsaicin-induced [Ca²⁺]_i increases in diabetic Ins2^+/Akita DRG neurons compared to wild-type DRG neurons. This may be because our Ins2^+/Akita diabetic mice had 9 months of diabetes, which is more comparable to end-stage diabetes.

In summary, we found that long-term diabetic Ins2^+/Akita DRG neurons exhibited decreased capsaicin-induced Ca²⁺ transients that decayed faster. High glucose-treated DRG neurons produced increased amounts of ROS. Although ROS is known to modulate TRPV1 function [15,45], it remains unclear whether ROS accumulation in Akita mice directly or indirectly results in TRPV1 function impairment. We propose that the accelerated decay rate of capsaicin-induced TRPV1 activity (Figure 4) may contribute to reduced pain sensation in end-stage diabetes.

4. Materials and Methods 4.1. Animals

All animal procedures were performed in accordance to the National Institutes of Health (NIH) guide and were approved by the Indiana University School of Medicine Institutional Animal Care and Use Committee (Animal Protocol #11165). Mice were euthanized using isoflurane anesthesia followed by decapitation. C57BL/6J wild-type and Ins2^+/Akita mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA) and bred in the animal facilities at the Indiana University School of Medicine.

4.2. Dorsal Root Ganglia (DRG) Neuron Isolation

DRG neurons were isolated from control C57BL/6J wild-type or Ins2^+/Akita mice using methods described previously [46]. Briefly, thoracic and lumbar (T1-L5) DRGs were collected and placed into cold Phosphate Buffered Saline (PBS) containing no Ca²⁺ or Mg²⁺. DRGs were digested in collagenase P (1 mg/mL, from Clostridium histolyticum, Roche, Indianapolis, IN, USA) solution in Hank’s Balanced Salt medium supplemented with 0.2 mM CaCl₂, 0.12% bovine serum albumin (BSA), and the Trypsin Inhibitor from soybean (0.1 mg/mL, Roche, Indianapolis, IN, USA) for 30 to 60 min. DRG neurons were dispersed by trituration and then plated onto Growth Factor Reduced Matrigel (Life Technologies, Grand Island, NY, USA)-coated 15 mm glass coverslips and cultured for 24 h in Minimum Essential Medium (Life Technologies) supplemented with 0.2% BSA, 100 U/mL penicillin, 100 μg/mL streptomycin, and 20 ng/mL NGF-2.5S (BD Biosciences, Bedford, MA, USA) at 37 °C in a water-jacketed 5% CO₂ incubator.

4.3. Whole-Cell Patch-Clamp Recordings

The capsaicin-activated TRPV1 currents were recorded from DRGs using an Axopatch 200B amplifier (Molecular Devices, San Jose, CA, USA) as indicated elsewhere [46,47,48,49,50]. Briefly, the analog data were digitized using an analog-digital converter Digidata 1440a at a sampling rate of 1 kHz. The currents were filtered at 3 kHz. Series resistance compensation was set to 50%. The external solution contained (in mM): 145 NaCl, 2.5 KCl, 1.2 CaCl₂, 1 MgCl₂, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 5.5 glucose (pH 7.2). The intracellular solution contained the following (in mM): 125 CsMeSO₃, 3.77 CaCl₂, 2 MgCl₂, 10 EGTA (100 nM free Ca²⁺), and 10 HEPES (pH 7.2). For TRPV1 current or voltage-gated calcium current recording in DRG neurons, 3 mM ATP-Mg was added into the intracellular solution. An episodic stimulation voltage protocol was used to record TRPV1 currents. Cells were voltage-clamped at a potential of −60 mV and voltage ramps from −100 to +100 mV were applied at 2-s intervals. The voltage protocol for voltage-gated calcium current was as follows: Cells were voltage-clamped at a holding potential of −80 mV, a 20 ms depolarizing pulse to 0 mV was used to transiently activate the voltage-gated calcium channels, and then a voltage ramps from −100 to +80 mV was applied. The voltage protocol was repeated with an interval of 15 s throughout the experiment. During the voltage-gated calcium current recordings, Ba²⁺ was used as a surrogate for Ca²⁺. The Ba²⁺ extracellular solution contained (in mM): 135 N-methyl-d-glucamine (NMDG)-Cl, 10 BaCl₂, 10 HEPES, and 5.5 glucose (pH 7.2). The pCLAMP 10 software package (Molecular Devices, San Jose, CA, USA) was used for acquisition control and data analyses. The current density was calculated by dividing the peak current by the cell capacitance. The data was obtained from 7 to 15 DRG neurons from 4 to 6 mice in each group. Data were fitted to a single exponential function. All of the experiments were performed at room temperature (22 to 25 °C).

4.4. Intracellular [Ca²⁺]_i Measurements

Fluorescence imaging experiments were performed as described previously [46,51]. Briefly, DRG neurons were loaded with Fura-2AM (4 µM) in Ca/Mg-PBS for one hour followed by an additional 30-minute incubation in Ca/Mg-PBS without Fura-2AM. A Till Photonics single-cell fluorescence imaging system was used to monitor intracellular Ca²⁺ changes in single Fura-2-loaded DRG neuron. The standard extracellular solution contained (in mM): 145 NaCl, 2.5 KCl, 1.2 CaCl₂, 1 MgCl₂, 10 HEPES, and 5.5 glucose (pH 7.2). 70 mM KCl (70 KCl) solution contained (in mM): 77.5 NaCl, 70 KCl, 1.2 CaCl₂, 1 MgCl₂, 10 HEPES, and 5.5 glucose (pH 7.2). The 15 mM KCl (15KCl) was obtained by mixing the standard extracellular solution and 70 KCl solution at a ratio of 11/2.5. The cells were superfused continuously with the test solutions at a rate of 1.5 mL/min. DRG neurons were identified by their appearance (round cells with processes). Only DRG neurons responding with pronounced Ca²⁺ influx upon KCl-induced depolarization were used for analyses. There were 3 to 6 mice used in each experimental group (20 to 150 isolated DRG neurons from one mouse in each single experiment).

4.5. ROS Measurements

To measure cytoplasmic ROS levels, we used OxiSelectTM Intracellular ROS Assay Kit (Green Fluorescence; Cell Biolabs, San Diego, CA, USA). DRG neurons from C57BL/6J mice were cultured in either control or high glucose for 7 days. For high glucose solution, the concentration of glucose was increased to 25 mM. Following this, the neurons were incubated for one hour at 37 °C with medium containing DCFH-DA (1 mM) and subsequently washed three times with PBS. A Till Photonics single-cell fluorescence imaging system was used to take the florescent images of neurons at room temperature. For each image, we defined regions of interest and measured the mean fluorescent intensity. The background-subtracted fluorescence intensity values were compared in control and high glucose DRG neurons to determine the ROS level increases under high glucose condition in DRG neurons.

4.6. Immunocytochemistry

Isolated DRGs were fixed in 10% neutral formalin and embedded in paraffin blocks and sectioned at 5 microns. Deparaffinized sections of the ganglia were incubated with the primary goat TRPV1 antibody in dilution buffer (3% normal horse serum and 0.04 Triton-x; Santa Cruz, Cat. # sc-398417; dilution factor: 1:100) overnight at 4 °C followed by three washes in PBS. The sections were then incubated with the secondary antibody (dilution factor: 1:1000, Donkey-anti-goat biotin-conjugated antibody, Sigma-Aldrich, St. Louis, MO, USA). After the secondary antibody was removed by multiple PBS washes, the sections were treated with horseradish peroxidase-conjugated streptavidin. The color was developed using diaminobenzidine. DRG sections (6 sections from each mouse) were randomly selected from wild-type (n = 7) or Ins2^+/Akita (n = 7) mice and TRPV1-expressing neurons were counted by blinded assayer using Image-Pro Premier 9.3 (Media Cybernetics, Rockville, MD, USA).

4.7. Chemicals

All inorganic salts and buffers were purchased from Sigma (St. Louis, MO, USA). The TRPV1 antibody was from Santa Cruz (Cat. # sc-398417, Dallas, TX, USA). Fura-2AM (Cat. # F-1221) was from Thermo Fisher Scientific (Waltham, MA, USA).

4.8. Statistical Analysis

The SigmaPlot 12 software (Systat software, San Jose, CA, USA) was used to perform the statistical analyses. The unpaired t test was used to determine the significant difference between two groups of data with normally distributed populations and equal variances, whereas the Mann–Whitney Rank Sum Test was used to determine the significant difference between two groups of data with non-normally distributed populations and different variances. The significance level was set to <0.05. All data were presented as mean ± standard error of the mean (SEM).

Figure 1. Transient receptor potential vanilloid type 1 (TRPV1) channel expression and capsaicin-evoked Ca2+ transients in dorsal root ganglion (DRG) neurons from wild-type and Ins2+/Akita mice at 9 months of diabetes. (A) Sample images of immunohistochemistry showing the expression of TRPV1 in DRG neurons of wild-type and Ins2+/Akita mice (Akita). Arrows indicate neurons with positive TRPV1 staining. (B) Percentage of TRPV1-positive neurons in wild-type and Ins2+/Akita (Akita) mice. The percentage of TRPV1-positive neurons was determined in six segments of each mouse DRG section and averaged. The dots represent the percentage determined for each wild-type or Ins2+/Akita mouse (n = seven mice for each condition; p = 0.0008). (C) Sample traces of time-course of capsaicin (Caps)-and 70 KCl-induced [Ca2+]i rises in DRG neurons isolated from one control or one Akita mouse. The experiments were repeated five to six times in DRG neurons isolated from additional five to six mice. Solid lines are averaged [Ca2+]i changes. The vertical lines represent SEM. The compounds were applied at the times indicated with the horizontal bars. The right inset shows the summary of fluorescence changes induced by 70 KCl. Each dot represents the averaged fluorescence change value determined during a fluorescence imaging experiment on a coverslip with 20 to 150 DRG neurons (n = 321-335 cells from five to six mice for each condition; p = 0.62). (D) The summary data of the average percentage of DRG neurons sensitive to capsaicin. Each dot represents the averaged percentage value determined in the tested cells from each mouse (n = five mice; p = 0.47). (E) Summary data of the areas under the response curves for C. Each dot represents the averaged area values determined for the tested cells on each coverslip. There were 20 to 150 isolated DRG neurons per coverslip from one mouse assessed in each experiment. Five wild-type and six Ins2+/Akita mice were used for these experiments. Only the neurons exhibiting Ca2+ increases in the presence of 70 KCl were included in the statistics. The t test was used to determine whether there was a significant difference between the tested groups (p = 0.027). * indicates p <0.05 and *** indicates p <0.001.

Figure 2. Voltage-gated calcium and TRPV1 currents in DRG neurons from wild-type and Ins2+/Akita mice. (A) Sample traces of current-voltage relationships acquired during the voltage ramps from -100 mV to +80 mV in wild-type (left) and Ins2+/Akita (Akita) DRG (right) neurons. The insets show the voltage-gated calcium currents activated by depolarizing pulses to 0 mV. (B) The summary data of the current densities recorded in wild-type and Ins2+/Akita (Akita) DRG neurons (p = 0.75). (C) Sample current traces obtained during the applications of 2 µM capsaicin (Caps) in wild-type and Ins2+/Akita (Akita) DRG neurons at a holding potential of -60 mV. The insets showed the fitted curves. A standard exponential function was used to fit to the current decay (red curve). (D) The summary data of capsaicin (Caps)-induced current densities for C (p = 0.27). (E) A comparison of the areas under the curves in the presence of capsaicin (Caps) in wild-type and Ins2+/Akita (Akita) DRG neurons (p = 0.036). (F) The summary data of the current decay tau values from wild-type and Ins2+/Akita DRGs. The t test was used to determine whether there was a significant difference between the tested groups (p = 0.002). * indicates p <0.05.

Figure 3. Effect of high glucose treatment on capsaicin (Caps)-induced [Ca2+]i rises and intracellular reactive oxygen species (ROS) accumulation in primary cultured DRG neurons. (A) Sample traces of time-course of [Ca2+]i changes in cultured DRG neurons isolated from one mouse (n = 91 neurons for control and n = 82 neurons for 25 HG). DRG neurons were treated with 5.5 mM (control, black) and 25 mM glucose (25HG, red) for 7 days. Solid and broken lines are averaged [Ca2+]i changes. The vertical lines represent SEM. The compounds were applied at the times indicated with the horizontal bars. The inset shows a comparison of 15 KCl-induced [Ca2+]i changes at the peak of the response in the control and 25HG groups. The data were averaged over five data points (n = 91 neurons for control and n = 82 neurons for 25 HG; Mann-Whitney Rank Sum Test, p ≤ 0.001). (B) Summary data of the areas under the capsaicin-induced [Ca2+]i response curves (sample curves are shown in A). The dots represent the averaged area under the curves determined for each mouse. There were 20 to 150 isolated DRG neurons per coverslip from one mouse assessed in each experiment. The experiments were repeated four times (n = four mice). The t test was used to determine whether there was a significant difference between the tested groups (p = 0.029). (C) The representative images of ROS detection by DCFH in DRG neurons treated with 5.5 mM (control) or 25 mM glucose (25HG) for 7 days. (D) Summary of data shown in C. ROS production was assessed in high glucose-treated DRG neurons (25HG) and control DRG neurons by measuring the DCFH fluorescence intensity. The dots represent the averaged values of DCFH fluorescence intensities calculated for each mouse. There were 77 to 256 isolated DRG neurons per coverslip from one mouse assessed in each experiment. The experiments were repeated four times (n = four mice). The t test was used to determine whether there was a significant difference between the tested groups (p = 0.017). * indicates p <0.05; *** indicates p <0.001.

Figure 4. Diagram shows the putative changes in TRPV1 functional activity in DRG neurons. The upper panel shows a healthy DRG neuron and the lower panel shows a DRG neuron in late-stage diabetes. Sample capsaicin-activated TRPV1 current traces are demonstrated for each condition. High glucose induces increased ROS production in DRG neurons. Accelerated current decay is a characteristic feature of capsaicin-activated TRPV1 currents in DRG neurons isolated from Akita mice at 9 months of diabetes.

Author Contributions

X.C., Y.D., and A.M.R. analyzed the data. A.M.R., X.C., F.A.W., M.B.G., and A.G.O. edited the manuscript. X.C., Y.D., and M.A.W. conducted experiments and acquired the data. X.C., A.M.R., F.A.W., M.B.G., and A.G.O. designed the described research studies and wrote the manuscript.

Funding

This work was funded by the National Institutes of Health, National Institute of Heart Lung and Blood Institute grants HL115140 (A.G.O.) and HL110170 (M.B.G.), National Eye Institute grants EY0126001, EY028037, and EY007739 (M.B.G.), BLR&D merit review grant I01BX002209 and National Institute of Neurological Disorders and Stroke grant NS102415 (F.A.W.).

Acknowledgments

We thank Minghua Zhong for help in analyzing the immunohistochemical images. We also thank Constance J. Temm from the Research Immunohistochemistry Facility at IUSM for performing the immunostainings of dorsal root ganglia.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

References

1. Salvotelli, L.; Stoico, V.; Perrone, F.; Cacciatori, V.; Negri, C.; Brangani, C.; Pichiri, I.; Targher, G.; Bonora, E.; Zoppini, G. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. J. Diabetes Complications 2015, 29, 1066-1070.

2. Van, A.K.; Bouhassira, D.; De, B.D.; Weiss, S.; Matthys, K.; Raemen, H.; Mathieu, C.; Colin, I.M. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009, 35, 206-213.

3. Suder, N.C.; Wukich, D.K. Prevalence of diabetic neuropathy in patients undergoing foot and ankle surgery. Foot Ankle Spec. 2012, 5, 97-101.

4. Chung, M.K.; Guler, A.D.; Caterina, M.J. TRPV1 shows dynamic ionic selectivity during agonist stimulation. Nat. Neurosci. 2008, 11, 555-564.

5. Ho, K.W.; Ward, N.J.; Calkins, D.J. TRPV1: A stress response protein in the central nervous system. Am. J. Neurodegener. Dis. 2012, 1, 1-14.

6. Premkumar, L.S.; Pabbidi, R.M. Diabetic peripheral neuropathy: Role of reactive oxygen and nitrogen species. Cell Biochem. Biophys. 2013, 67, 373-383.

7. Sanchez, J.F.; Krause, J.E.; Cortright, D.N. The distribution and regulation of vanilloid receptor VR1 and VR1 5' splice variant RNA expression in rat. Neuroscience 2001, 107, 373-381.

8. Vandewauw, I.; Owsianik, G.; Voets, T. Systematic and quantitative mRNA expression analysis of TRP channel genes at the single trigeminal and dorsal root ganglion level in mouse. BMC. Neurosci. 2013, 14, 21.

9. Fukuoka, T.; Tokunaga, A.; Tachibana, T.; Dai, Y.; Yamanaka, H.; Noguchi, K. VR1, but not P2X3, increases in the spared L4 DRG in rats with L5 spinal nerve ligation. Pain 2002, 99, 111-120.

10. Hong, S.; Wiley, J.W. Altered expression and function of sodium channels in large DRG neurons and myelinated A-fibers in early diabetic neuropathy in the rat. Biochem. Biophys. Res. Commun. 2006, 339, 652-660.

11. Li, Y.; Cai, J.; Han, Y.; Xiao, X.; Meng, X.L.; Su, L.; Liu, F.Y.; Xing, G.G.; Wan, Y. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain. Eur. J. Pain 2014, 18, 774-784.

12. Hicks, G.A. TRP channels as therapeutic targets: Hot property, or time to cool down? Neurogastroenterol. Motil. 2006, 18, 590-594.

13. Pabbidi, R.M.; Yu, S.Q.; Peng, S.; Khardori, R.; Pauza, M.E.; Premkumar, L.S. Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity. Mol. Pain 2008, 4, 9.

14. Volpe, C.M.O.; Villar-Delfino, P.H.; Dos Anjos, P.M.F.; Nogueira-Machado, J.A. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death. Dis. 2018, 9, 119. [Green Version]

15. Chuang, H.H.; Lin, S. Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification. Proc. Natl. Acad. Sci. USA 2009, 106, 20097-20102. [Green Version]

16. DelloStritto, D.J.; Connell, P.J.; Dick, G.M.; Fancher, I.S.; Klarich, B.; Fahmy, J.N.; Kang, P.T.; Chen, Y.R.; Damron, D.S.; Thodeti, C.K.; et al. Differential regulation of TRPV1 channels by H2O2: Implications for diabetic microvascular dysfunction. Basic Res. Cardiol. 2016, 111, 21.

17. Susztak, K.; Raff, A.C.; Schiffer, M.; Bottinger, E.P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006, 55, 225-233.

18. Wang, J.; Takeuchi, T.; Tanaka, S.; Kubo, S.K.; Kayo, T.; Lu, D.; Takata, K.; Koizumi, A.; Izumi, T. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J. Clin. Invest. 1999, 103, 27-37.

19. Yoshioka, M.; Kayo, T.; Ikeda, T.; Koizumi, A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997, 46, 887-894.

20. Duan, Y.; Beli, E.; Li, C.S.; Quigley, J.L.; Miller, R.C.; Moldovan, L.; Feng, D.; Salazar, T.E.; Hazra, S.; Al-Sabah, J.; et al. Loss of Angiotensin-Converting Enzyme 2 Exacerbates Diabetic Retinopathy by Promoting Bone Marrow Dysfunction. Stem Cells 2018, 36, 1430-1440.

21. Vastani, N.; Guenther, F.; Gentry, C.; Austin, A.L.; King, A.J.; Bevan, S.; Andersson, D.A. Impaired Nociception in the Diabetic Ins2+/Akita Mouse. Diabetes 2018, 67, 1650-1662.

22. Cao, X.H.; Byun, H.S.; Chen, S.R.; Cai, Y.Q.; Pan, H.L. Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor. J. Neurochem. 2010, 114, 1460-1475.

23. Aranda, A.; Sequedo, L.; Tolosa, L.; Quintas, G.; Burello, E.; Castell, J.V.; Gombau, L. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: A quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol. In Vitro 2013, 27, 954-963.

24. Oyama, Y.; Hayashi, A.; Ueha, T.; Maekawa, K. Characterization of 2',7'-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide. Brain Res. 1994, 635, 113-117.

25. Lam, D.; Momeni, Z.; Theaker, M.; Jagadeeshan, S.; Yamamoto, Y.; Ianowski, J.P.; Campanucci, V.A. RAGE-dependent potentiation of TRPV1 currents in sensory neurons exposed to high glucose. PLoS ONE 2018, 13, e0193312.

26. Akude, E.; Zherebitskaya, E.; Chowdhury, S.K.; Smith, D.R.; Dobrowsky, R.T.; Fernyhough, P. Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats. Diabetes 2011, 60, 288-297.

27. Cui, Y.Y.; Xu, H.; Wu, H.H.; Qi, J.; Shi, J.; Li, Y.Q. Spatio-temporal expression and functional involvement of transient receptor potential vanilloid 1 in diabetic mechanical allodynia in rats. PLoS ONE 2014, 9, e102052.

28. Liu, C.; Li, C.; Deng, Z.; Du, E.; Xu, C. Long Non-coding RNA BC168687 is Involved in TRPV1-mediated Diabetic Neuropathic Pain in Rats. Neuroscience 2018, 374, 214-222.

29. Van Buren, J.J.; Bhat, S.; Rotello, R.; Pauza, M.E.; Premkumar, L.S. Sensitization and translocation of TRPV1 by insulin and IGF-I. Mol. Pain 2005, 1, 17.

30. Gallego-Sandin, S.; Rodriguez-Garcia, A.; Alonso, M.T.; Garcia-Sancho, J. The endoplasmic reticulum of dorsal root ganglion neurons contains functional TRPV1 channels. J. Biol. Chem. 2009, 284, 32591-32601.

31. Eberhardt, M.J.; Filipovic, M.R.; Leffler, A.; de la Roche, J.; Kistner, K.; Fischer, M.J.; Fleming, T.; Zimmermann, K.; Ivanovic-Burmazovic, I.; Nawroth, P.P.; et al. Methylglyoxal activates nociceptors through transient receptor potential channel A1 (TRPA1): A possible mechanism of metabolic neuropathies. J. Biol. Chem. 2012, 287, 28291-28306.

32. Bestall, S.M.; Hulse, R.P.; Blackley, Z.; Swift, M.; Ved, N.; Paton, K.; Beazley-Long, N.; Bates, D.O.; Donaldson, L.F. Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditions. J. Cell Sci. 2018, 131.

33. Koplas, P.A.; Rosenberg, R.L.; Oxford, G.S. The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons. J. Neurosci. 1997, 17, 3525-3537.

34. Sanz-Salvador, L.; Andres-Borderia, A.; Ferrer-Montiel, A.; Planells-Cases, R. Agonist- and Ca2+-dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation. J. Biol. Chem. 2012, 287, 19462-19471.

35. Planells-Cases, R.; Garcia-Sanz, N.; Morenilla-Palao, C.; Ferrer-Montiel, A. Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia. Pflugers Arch. 2005, 451, 151-159.

36. Mohapatra, D.P.; Nau, C. Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase. J. Biol. Chem. 2005, 280, 13424-13432.

37. Rosenbaum, T.; Gordon-Shaag, A.; Munari, M.; Gordon, S.E. Ca2+/calmodulin modulates TRPV1 activation by capsaicin. J. Gen. Physiol. 2004, 123, 53-62.

38. Liu, B.; Zhang, C.; Qin, F. Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate. J. Neurosci. 2005, 25, 4835-4843.

39. Bhave, G.; Zhu, W.; Wang, H.; Brasier, D.J.; Oxford, G.S.; Gereau, R.W. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002, 35, 721-731.

40. Garcia-Santamarina, S.; Boronat, S.; Hidalgo, E. Reversible cysteine oxidation in hydrogen peroxide sensing and signal transduction. Biochemistry 2014, 53, 2560-2580.

41. Ruparel, N.B.; Patwardhan, A.M.; Akopian, A.N.; Hargreaves, K.M. Homologous and heterologous desensitization of capsaicin and mustard oil responses utilize different cellular pathways in nociceptors. Pain 2008, 135, 271-279. [Green Version]

42. Weng, H.J.; Patel, K.N.; Jeske, N.A.; Bierbower, S.M.; Zou, W.; Tiwari, V.; Zheng, Q.; Tang, Z.; Mo, G.C.; Wang, Y.; et al. Tmem100 Is a Regulator of TRPA1-TRPV1 Complex and Contributes to Persistent Pain. Neuron 2015, 85, 833-846. [Green Version]

43. Masuoka, T.; Kudo, M.; Yamashita, Y.; Yoshida, J.; Imaizumi, N.; Muramatsu, I.; Nishio, M.; Ishibashi, T. TRPA1 Channels Modify TRPV1-Mediated Current Responses in Dorsal Root Ganglion Neurons. Front. Physiol. 2017, 8, 272.

44. Arenas, O.M.; Zaharieva, E.E.; Para, A.; Vasquez-Doorman, C.; Petersen, C.P.; Gallio, M. Activation of planarian TRPA1 by reactive oxygen species reveals a conserved mechanism for animal nociception. Nat. Neurosci. 2017, 20, 1686-1693. [Green Version]

45. Kim, K.S.; Yoo, H.Y.; Park, K.S.; Kim, J.K.; Zhang, Y.H.; Kim, S.J. Differential effects of acute hypoxia on the activation of TRPV1 by capsaicin and acidic pH. J. Physiol. Sci. 2012, 62, 93-103.

46. Chen, X.; Sun, W.; Gianaris, N.G.; Riley, A.M.; Cummins, T.R.; Fehrenbacher, J.C.; Obukhov, A.G. Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel. J. Biol. Chem. 2014, 289, 9600-9610.

47. Obukhov, A.G.; Schultz, G.; Luckhoff, A. Regulation of heterologously expressed transient receptor potential-like channels by calcium ions. Neuroscience 1998, 85, 487-495.

48. Kumar, S.; Chakraborty, S.; Barbosa, C.; Brustovetsky, T.; Brustovetsky, B.; Obukhov, A.G. Mechanisms controlling neurite outgrowth in a pheochromocytoma cell line: The role of TRPC channels. J. Cell. Physiol. 2011, 227, 1408-1409.

49. Chen, X.; Li, W.; Riley, A.M.; Soliman, M.; Chakraborty, S.; Stamatkin, C.W.; Obukhov, A.G. Molecular Determinants of the Sensitivity to Gq/11-Phospholipase C-dependent Gating, Gd3+ Potentiation, and Ca2+ Permeability in the Transient Receptor Potential Canonical Type 5 (TRPC5) Channel. J. Biol. Chem. 2017, 292, 898-911.

50. Chakraborty, S.; Berwick, Z.C.; Bartlett, P.J.; Kumar, S.; Thomas, A.P.; Sturek, M.; Tune, J.D.; Obukhov, A.G. Bromoenol lactone inhibits voltage-gated Ca2+ and transient receptor potential canonical channels. J. Pharmacol. Exp. Ther. 2011, 339, 329-340.

51. Chen, X.; Egly, C.; Riley, A.M.; Li, W.; Tewson, P.; Hughes, T.E.; Quinn, A.M.; Obukhov, A.G. PKC-dependent Phosphorylation of the H1 Histamine Receptor Modulates TRPC6 Activity. Cells 2014, 3, 247-257. [Green Version]